Connect with us

Press Release

CytoMed Therapeutics Ltd — A Rising Star in Singapore’s Cancer Biotechnology Sector

Published

4 months ago

on

In February 2026, The Wall Street Transcript published an exclusive interview with CytoMed Therapeutics Ltd (NASDAQ: GDTC) Chairman Choo Chee Kong. The interview covered the company’s technological approach, clinical trial progress, global strategic expansion — particularly in China and India — financing status, and deep insights into the global biotechnology industry.
 
 1. Company Overview & Core Technology
Company Background
CytoMed is a clinical-stage biotech spin-off from ASTAR, Singapore’s national scientific research agency. The company focuses on developing affordable cancer therapy using patented allogeneic Gamma Delta T Cells derived from healthy donors.
Mission
The company aims to address the major limitations of existing cell therapies such as CAR-T, including high treatment costs and lengthy manufacturing timelines. By using blood from healthy donors to manufacture “off-the-shelf” immune cells, the company aims to reduce production costs and enable global distribution.
Technological Advantages
Safety
Gamma Delta T Cells have a lower risk of causing Graft-versus-Host Disease (GVHD), making them suitable for allogeneic transplantation.
Versatility
The cells express CARs (Chimeric Antigen Receptors) targeting NKG2D ligands, enabling recognition of multiple cancer types that express stress-related molecules, including Solid tumors & Hematological malignancies.
 
 2. Clinical Trial Progress
Singapore ANGELICA Trial
Nature of the Trial
Ongoing first-in-human clinical trial targeting patients with:
Advanced solid tumors
Hematological malignancies
Progress
The trial comprised 12 patients in total, and treatment has been completed for half of the participants (6 patients).
Objective
To complete the Phase 1 clinical trial and evaluate before embarking on Phase 2 by next year 2027:
Safety
Efficacy of the CAR-modified version
 
Malaysia Clinical Trial
Strategy
CytoMed plans to launch a first-in-human clinical trial for the unmodified version of the therapy, which is expected to be significantly less expensive than the CAR-T version.
Collaboration
The company is collaborating with Universiti Malaya Hospital and is preparing to submit trial documentation to regulators and start by this year 2026.

3. Strategic Expansion & Acquisitions
Acquisition of TC BioPharm (UK)
Through this acquisition, CytoMed obtained feeder-free manufacturing technology, solving logistical challenges associated with cross-border transportation of specialized feeder cells and strengthening its cancer therapy platform.
 
Acquisition of Longevity Bank (Malaysia)
Background
In mid-2024, CytoMed acquired a Malaysian cord blood bank that had entered liquidation due to the impact of the pandemic. The bank had approximately 12,000 customers.
Strategic Purpose
The acquisition provides access to cord blood resources for the development of Natural Killer (NK) Cell therapies from pristine cord blood.
NK cells have potential applications in:
Anti-aging
Elimination of senescent cells
This acquisition also broadens the company’s therapeutic pipeline.
 
 4. Global Market Strategy: Focus on China & India
China (Key Strategic Focus)
Policy Opportunity
CytoMed is closely monitoring China’s “Directive 818,” which allows hospitals conducting investigator-initiated trials (IITs) to charge patients, thereby helping subsidize biotechnology companies’ R&D and manufacturing costs.
Competitive Advantage
Compared with the capital-intensive “cash-burning” model commonly seen in Western biotech companies, the Chinese model is viewed as more sustainable.
China’s Government-backed biotech parks, Pragmatic regulatory policies & Strong venture capital ecosystem have made the country highly attractive for biotechnology development.
Market Potential
China has a massive cancer patient population and  regulatory flexibility for compassionate-use style commercialization making it a critical strategic market for CytoMed.
 
India
As one of the world’s two largest population centres, India is also a major target market for the company.
 
United States
Although CytoMed collaborates with MD Anderson Cancer Center — where animal studies showed effectiveness against AML — the company currently does not prioritize the U.S. market due to the long time and extremely high cost of clinical trials.
 
 5. Financial Position & Industry Perspectives
Financial Status
The company raised only USD 8 million during its 2023 IPO due to difficult biotech market conditions at the time.
However, management has maintained disciplined spending while seeking partners to co-develop its proprietary allogeneic cancer technologies.

View on the “Biotech Winter”
The Chairman believes the biotech industry is currently experiencing a “winter” caused by:
Excessively high valuations during the pandemic era
SPAC-related speculation
Significant investor losses
Tightening capital markets
The company also faces:
Heavy short-selling pressure
Interference from day traders

Strategic Pivot
To survive the difficult funding environment, CytoMed is shifting toward closer collaboration with hospitals to provide treatments for “no-option” patients.
The company benefits from low cost infrastructure in Southeast Asia and aims to:
Attract international medical tourists
Leverage Malaysia’s “Medical Tourism Year 2026”
Generate revenue while simultaneously collecting clinical data
 
 6. Regulatory Advocacy
Compassionate Use
CytoMed advocates for regulators to adopt a more flexible approach for terminal patients who have exhausted all available treatment options, allowing access to new cell therapies.
East-West Differences
The Chairman noted that Eastern societies, particularly in Southeast Asia, generally have less aggressive litigation cultures compared with Western countries such as the United States.
This creates a more favourable environment for Compassionate Use programs, allowing terminal patients to try innovative therapies when conventional options have failed.
 
Conclusion
The interview highlights CytoMed’s unique “low-cost survival strategy” within the highly expensive biotechnology sector.
By leveraging:
Southeast Asia’s lower manufacturing and labour costs
Strategic hospital partnerships
China’s “Directive 818” policy framework
the company has identified a pragmatic commercialization pathway during the ongoing biotech capital winter.
CytoMed’s approach demonstrates not only technological ambition, but also strong strategic insight into the evolving global biotechnology landscape.
 

Media Contact: 

Media Relations
CytoMed Therapeutics Ltd
Singapore
https://www.cytomed.sg/

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Related Topics:
Continue Reading

Press Release

Oversized QuickBooks Files? SuperCondense Improves Performance, Speed, and Stability

Published

7 minutes ago

on

September 16, 2026

By

Brandon, MB, Sep 16, 2026, ZEX PR WIRE — For many growing businesses, QuickBooks performance gradually declines as company files become larger and more complex. Slow loading times, delayed reports, system instability, and productivity bottlenecks can impact daily operations and frustrate users. QuickBooksRepairPro.com (QBRP) is helping businesses address these challenges through its specialized SuperCondense file optimization service.

As QuickBooks company files accumulate years of transactions, list entries, and historical data, performance issues can become increasingly noticeable. Common symptoms include slow startup times, delayed searches, lengthy report generation, frequent system lag, and reduced responsiveness in multi-user environments.

“Many organizations accept poor QuickBooks performance as a normal part of growth,” said a spokesperson for QuickBooksRepairPro. “In reality, oversized company files can often be optimized to deliver significant improvements in speed, stability, and user experience.”

SuperCondense is designed to safely reduce file size and improve efficiency while preserving the usability and integrity of critical accounting data. The service helps businesses streamline large QuickBooks files without disrupting daily operations or compromising essential financial information.

Signs Your QuickBooks File May Be Too Large

  • Slow file opening and closing times
  • Delayed report generation
  • Sluggish data entry and searches
  • Performance issues in multi-user mode
  • Increased risk of file instability

Benefits of SuperCondense

  • Improved QuickBooks speed and responsiveness
  • Enhanced file stability and reliability
  • More efficient multi-user performance
  • Reduced system frustration for employees
  • Faster day-to-day accounting workflows

By optimizing oversized company files, QuickBooksRepairPro helps businesses restore productivity, improve user satisfaction, and maximize the performance of their QuickBooks environment.

For more information about SuperCondense services, visit QuickBooksRepairPro.com.

About QuickBooks Repair Pro

QuickBooksRepairpro.com is a leading QuickBooks File Repair and Data Recovery, QuickBooks Conversion, QuickBooks Mac Repair, and QuickBooks SDK programming services provider in North America, serving thousands of business users all over the world. With over 20 years of experience with Intuit QuickBooks, QuickBooksRepairpro.com assists QuickBooks users and small businesses with a variety of services and work with the US, UK, Canadian, Australian (Reckon Accounts), and New Zealand versions of QuickBooks (PC and Mac platforms).

For more information, visit https://quickbooksrepairpro.com/

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

Recovering Decades of Financial Data: QuickBooksRepairPro Supports Legacy QuickBooks Files

Published

22 minutes ago

on

September 16, 2026

By

Brandon, MB, Sep 16, 2026, ZEX PR WIRE — Historical financial records remain critical for audits, tax compliance, litigation support, and long-term business continuity. QuickBooksRepairPro.com (QBRP) is helping organizations recover and access valuable accounting data from virtually every QuickBooks version, including legacy releases that may no longer be supported.

Many businesses discover that years of financial history are stored in archived QuickBooks company files that can be difficult or impossible to open using modern systems. Obsolete software versions, damaged files, aging hardware, and compatibility issues often create barriers to accessing essential accounting records when they are needed most.

QuickBooksRepairPro specializes in recovering, repairing, and converting QuickBooks files across multiple generations of the software, enabling businesses to regain access to historical financial information while supporting compliance and operational requirements.

“Financial records often remain important long after a QuickBooks version has been retired,” said a spokesperson for QuickBooksRepairPro. “Whether organizations are preparing for an audit, responding to a legal request, or reviewing historical performance, access to complete accounting data is essential.”

Key benefits include:

  • Recovery of archived and legacy QuickBooks company files
  • Support for older and obsolete QuickBooks versions
  • Assistance with data conversion and migration
  • Access to records needed for tax and legal compliance
  • Preservation of critical historical accounting information

By combining decades of QuickBooks expertise with advanced recovery capabilities, QuickBooksRepairPro helps businesses unlock years of valuable financial history and maintain continuity across changing technology environments.

For more information, visit QuickBooksRepairPro.com.

About QuickBooks Repair Pro

QuickBooksRepairpro.com is a leading QuickBooks File Repair and Data Recovery, QuickBooks Conversion, QuickBooks Mac Repair, and QuickBooks SDK programming services provider in North America, serving thousands of business users all over the world. With over 20 years of experience with Intuit QuickBooks, QuickBooksRepairpro.com assists QuickBooks users and small businesses with a variety of services and work with the US, UK, Canadian, Australian (Reckon Accounts), and New Zealand versions of QuickBooks (PC and Mac platforms).

For more information, visit https://quickbooksrepairpro.com/

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

Press Release

New PerpetualBooks Playbook Helps Businesses Maximize Long-Term Value of QuickBooks Desktop 2024

Published

22 minutes ago

on

September 16, 2026

By

Brandon, MB, Sep 16, 2026, ZEX PR WIRE — PerpetualBooks today announced the publication of its new Long-Term Ownership Playbook for QuickBooks Desktop 2024, a comprehensive resource designed to help businesses navigate long-term software ownership, operational planning, and ongoing utilization of QuickBooks Desktop 2024.

As organizations seek greater control over accounting software costs and long-term financial system stability, the playbook provides actionable guidance on maintaining business continuity, managing accounting workflows, protecting financial data, and planning for future technology requirements.

The publication addresses key topics including:

  • Long-term ownership considerations for QuickBooks Desktop 2024
  • Data management and backup best practices
  • Compliance and operational continuity planning
  • Strategies for maximizing return on software investment
  • Practical recommendations for businesses maintaining desktop accounting environments

“Many businesses continue to value the reliability, familiarity, and control offered by desktop accounting software,” said a spokesperson for PerpetualBooks. “This playbook provides organizations with a clear framework for making informed decisions about their QuickBooks Desktop 2024 environment and long-term accounting technology strategy.”

The Long-Term Ownership Playbook is intended for small and medium-sized businesses, accountants, bookkeepers, consultants, and business owners seeking practical guidance on sustaining their accounting operations while maximizing the value of their existing software investments.

The guide is now available through PerpetualBooks and can be accessed by businesses evaluating long-term accounting software ownership options.

About PerpetualBooks

PerpetualBooks helps businesses make informed decisions about accounting software ownership and continuity planning. By providing educational resources, expert insights, and practical guidance, PerpetualBooks supports organizations seeking long-term value from their accounting technology investments.

About Author

Cloud PR Wire

See author's posts

Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Digi Observer journalist was involved in the writing and production of this article.

Continue Reading

LATEST POST

Like Us
Follow Us
Subscribe Us
Follow Us